Advisornet Financial’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $943K | Buy |
17,988
+17
| +0.1% | +$899 | 0.04% | 282 |
|
|
2026
Q1 | $992K | Sell |
17,971
-487
| -3% | -$26.4K | 0.05% | 258 |
|
|
2025
Q4 | $905K | Buy |
18,458
+286
| +2% | +$13.3K | 0.05% | 275 |
|
|
2025
Q3 | $784K | Sell |
18,172
-144
| -0.8% | -$5.63K | 0.04% | 290 |
|
|
2025
Q2 | $703K | Sell |
18,316
-1,472
| -7% | -$56.2K | 0.05% | 304 |
|
|
2025
Q1 | $767K | Sell |
19,788
-1,247
| -6% | -$45.7K | 0.06% | 266 |
|
|
2024
Q4 | $711K | Sell |
21,035
-247
| -1% | -$8.89K | 0.06% | 244 |
|
|
2024
Q3 | $870K | Buy |
21,282
+2,008
| +10% | +$82.1K | 0.07% | 244 |
|
|
2024
Q2 | $742K | Sell |
19,274
-1,779
| -8% | -$74.8K | 0.07% | 245 |
|
|
2024
Q1 | $903K | Buy |
21,053
+324
| +2% | +$13.4K | 0.09% | 218 |
|
|
2023
Q4 | $768K | Buy |
20,729
+377
| +2% | +$13.5K | 0.07% | 253 |
|
|
2023
Q3 | $738K | Sell |
20,352
-586
| -3% | -$20.8K | 0.07% | 247 |
|
|
2023
Q2 | $746K | Sell |
20,938
-370
| -2% | -$13.3K | 0.06% | 247 |
|
|
2023
Q1 | $758K | Buy |
21,308
+73
| +0.3% | +$2.55K | 0.07% | 243 |
|
|
2022
Q4 | $746K | Sell |
21,235
-15,802
| -43% | -$526K | 0.07% | 245 |
|
|
2022
Q3 | $1.09M | Buy |
37,037
+16,688
| +82% | +$632K | 0.11% | 195 |
|
|
2022
Q2 | $1.11M | Buy |
20,349
+1,059
| +5% | +$58.5K | 0.11% | 193 |
|
|
2022
Q1 | $1.05M | Sell |
19,290
-168
| -0.9% | -$9.13K | 0.07% | 239 |
|
|
2021
Q4 | $1.07M | Sell |
19,458
-5,384
| -22% | -$280K | 0.07% | 248 |
|
|
2021
Q3 | $1.19M | Buy |
24,842
+6,128
| +33% | +$308K | 0.08% | 207 |
|
|
2021
Q2 | $932K | Sell |
18,714
-382
| -2% | -$18.4K | 0.06% | 266 |
|
|
2021
Q1 | $852K | Buy |
19,096
+1,339
| +8% | +$60.8K | 0.06% | 268 |
|
|
2020
Q4 | $817K | Sell |
17,757
-68
| -0.4% | -$3.12K | 0.07% | 255 |
|
|
2020
Q3 | $839K | Buy |
17,825
+2,204
| +14% | +$110K | 0.07% | 242 |
|
|
2020
Q2 | $796K | Buy |
15,621
+724
| +5% | +$37.1K | 0.06% | 253 |
|
|
2020
Q1 | $706K | Buy |
14,897
+1,316
| +10% | +$70.2K | 0.07% | 241 |
|
|
2019
Q4 | $798K | Sell |
13,581
-570
| -4% | -$31.7K | 0.07% | 247 |
|
|
2019
Q3 | $755K | Buy |
14,151
+644
| +5% | +$33.1K | 0.07% | 254 |
|
|
2019
Q2 | $676K | Sell |
13,507
-510
| -4% | -$25.6K | 0.07% | 262 |
|
|
2019
Q1 | $732K | Buy |
14,017
+4
| +0% | +$200 | 0.09% | 216 |
|
|
2018
Q4 | $669K | Buy |
14,013
+506
| +4% | +$24.9K | 0.09% | 206 |
|
|
2018
Q3 | $678K | Buy |
13,507
+387
| +3% | +$19.7K | 0.09% | 222 |
|
|
2018
Q2 | $661K | Buy |
13,120
+2,254
| +21% | +$114K | 0.09% | 198 |
|
|
2018
Q1 | $531K | Buy |
10,866
+828
| +8% | +$38.6K | 0.07% | 218 |
|
|
2017
Q4 | $445K | Buy |
+10,038
| New | +$464K | 0.07% | 216 |
|
Other funds holding GSK
JEST
Advisornet Financial's GSK Position: Q2 2026 in Review
Advisornet Financial increased its GSK (GSK) stake by 0.09% in Q2 2026, buying an estimated $899 and bringing the position to 17,988 shares worth $943K. The position accounts for 0.04% of the portfolio, ranked #282.
Advisornet Financial first reported a position in GSK in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.19M in Q3 2021. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.
- Advisornet Financial held 17,988 shares of GSK worth $943K as of Q2 2026.
- Advisornet Financial bought 17 GSK shares in Q2 2026, an estimated $899.
- GSK made up 0.04% of Advisornet Financial's portfolio in Q2 2026, its #282 holding.
- Advisornet Financial first reported a position in GSK in Q4 2017 and has held it in 35 quarters since.
- Advisornet Financial's GSK position peaked at $1.19M in Q3 2021.
- 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.
Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.